Navigation Links
Quanterix Corporation Announces the Addition of Dr. Robert Corn to its Scientific Advisory Board
Date:11/11/2008

Leader in single molecule detection to expand prominent Scientific Advisory

Board

CAMBRIDGE, Mass., Nov. 11 /PRNewswire/ -- Quanterix Corporation, the leader in single molecule detection, announced today that Robert Corn, Ph.D. has joined its Scientific Advisory Board (SAB). Dr. Corn is a Professor in the Departments of Chemistry and Biomedical Engineering at the University of California, Irvine. Dr. Corn's primary research areas include the development of new methods for detecting binding of biomolecules to surfaces and chemical modification strategies to control specific and non-specific adsorption of biopolymers to a variety of surfaces.

Dr. David Walt, Scientific Founder of Quanterix and Chair of the SAB, stated, "Dr. Corn is a leader in the field of surface chemistry; his research interests and experience are directly applicable to our Single Molecule Array (SiMoA(TM)) technology. We are eager to draw upon his extensive knowledge and insight as we develop assays and instrumentation that enable unparalleled increases in analytical sensitivity for the detection of proteins implicated in a variety of diseases."

Dr. Corn added, "The novel technology platform being developed by Quanterix will provide medical researchers with a unique tool that allows low abundance biomarkers to be detected in complex biological samples. I am excited to join such a world class Advisory Board and look forward to working with the other members to further advance this promising technology."

Dr. Corn joins SAB members David Walt, Ph.D., Robinson Professor of Chemistry and Howard Hughes Medical Institute Professor, Tufts University (Chairman of the SAB), Larry J. Kricka, D. Phil., Professor of Pathology and Laboratory Medicine at the University of Pennsylvania and Director of the General Chemistry Laboratory at the Hospital of the University of Pennsylvania, J. Michael Ramsey, Ph.D., Minnie N. Goldby Distinguished Professor of Chemistry and Chair at the University of North Carolina at Chapel Hill, and Sunney Xie, Ph.D., Professor of Chemistry at Harvard University.

About Quanterix

Quanterix is developing a revolutionary Single Molecule Array (SiMoA(TM)) technology that allows the behavior of thousands of individual molecules to be observed simultaneously, rather than an ensemble average of many molecules as with existing technologies. Quanterix's platform will bring an unprecedented level of sensitivity, precision, and assay robustness to clinical diagnostics, drug development, and life science research. The first application that Quanterix is pursuing with the SiMoA(TM) technology is the detection and quantification of proteins present in blood and other body fluids at very low, previously undetectable, concentrations. Diagnostic assays targeting proteins that have been implicated in a variety of human diseases, including cancer, chronic inflammatory disease and cardiovascular disease are under development. Quanterix is a privately held company located in Cambridge, Massachusetts and is backed by leading life science investors including ARCH Venture Partners, Bain Capital Ventures, and Flagship Ventures. For additional information, please visit http://www.quanterix.com.


'/>"/>
SOURCE Quanterix Corporation
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Azur Pharma and Elan Corporation (NYSE: ELN) Sign Agreement to Develop a Once-Daily Clozapine
2. Medical Simulation Corporation Announces Partnership With University of South Florida
3. Environmental Power Corporation and Organix, Inc. Establish Alliance to Produce High Value Soil Amendment Products
4. Environmental Tectonics Corporation Announces Staff Addition to Its BioMedical Systems Division
5. Verenium Corporation to Speak at the Credit Suisse Alternative Energy Conference
6. Health Robotics Announces Contract for its CytoCare(TM) and IV Station(TM) Robots With Arabian Health Care Supply Corporation
7. DURECT Corporation Announces Third Quarter 2008 Financial Results
8. Verenium Corporation to Announce Third Quarter 2008 Financial Results
9. Environmental Tectonics Corporations Simulation Division Receives New ADMS Contract from Netherlands Institute for Safety
10. AMERIGROUP Corporation Named One of Best Places to Work in Healthcare
11. STERIS Corporation Announces Fiscal 2009 Second Quarter and First Half Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/10/2017)... (PRWEB) , ... October 10, ... ... development-stage cancer-focused pharmaceutical company advancing targeted antibody-drug conjugate (ADC) therapeutics, today confirmed ... targeted HPLN (Hybrid Polymerized Liposomal Nanoparticle), a technology developed in collaboration with ...
(Date:10/10/2017)... ... 10, 2017 , ... Dr. Bob Harman, founder and CEO of VetStem ... The event entitled “Stem Cells and Their Regenerative Powers,” was held ... Harman, DVM, MPVM was joined by two human doctors: Peter B. Hanson, M.D., Chief ...
(Date:10/10/2017)... CRUZ, Calif. , Oct. 10, 2017 ... grant from the NIH to develop RealSeq®-SC (Single Cell), ... kit for profiling small RNAs (including microRNAs) from single ... Analysis Program highlights the need to accelerate development of ... "New techniques for measuring ...
(Date:10/10/2017)... ... October 10, 2017 , ... The Pittcon Program Committee ... honoring scientists who have made outstanding contributions to analytical chemistry and applied ... the world’s leading conference and exposition for laboratory science, which will be held ...
Breaking Biology Technology:
(Date:4/11/2017)... , April 11, 2017 Crossmatch®, a ... authentication solutions, today announced that it has been ... Research Projects Activity (IARPA) to develop next-generation Presentation ... "Innovation has been a driving force ... program will allow us to innovate and develop ...
(Date:4/11/2017)... N.Y. , April 11, 2017 ... fingerprints, but researchers at the New York University ... College of Engineering have found that partial similarities ... security systems used in mobile phones and other ... thought. The vulnerability lies in the ...
(Date:4/6/2017)... 2017 Forecasts by Product Type ... by End-Use (Transportation & Logistics, Government & Public Sector, ... Fossil Generation Facility, Nuclear Power), Industrial, Retail, Business Organisation ... Are you looking for a definitive report on the ... ...
Breaking Biology News(10 mins):